These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease. Zainaghi IA; Talib LL; Diniz BS; Gattaz WF; Forlenza OV J Neural Transm (Vienna); 2012 Jul; 119(7):815-9. PubMed ID: 22573143 [TBL] [Abstract][Full Text] [Related]
10. Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients. Sennvik K; Fastbom J; Blomberg M; Wahlund LO; Winblad B; Benedikz E Neurosci Lett; 2000 Jan; 278(3):169-72. PubMed ID: 10653020 [TBL] [Abstract][Full Text] [Related]
11. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex. Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051 [TBL] [Abstract][Full Text] [Related]
12. Platelets and Alzheimer's disease: Potential of APP as a biomarker. Evin G; Li QX World J Psychiatry; 2012 Dec; 2(6):102-13. PubMed ID: 24175176 [TBL] [Abstract][Full Text] [Related]
13. Increased Serum Beta-Secretase 1 Activity is an Early Marker of Alzheimer's Disease. Nicsanu R; Cervellati C; Benussi L; Squitti R; Zanardini R; Rosta V; Trentini A; Ferrari C; Saraceno C; Longobardi A; Bellini S; Binetti G; Zanetti O; Zuliani G; Ghidoni R J Alzheimers Dis; 2022; 87(1):433-441. PubMed ID: 35275540 [TBL] [Abstract][Full Text] [Related]
14. Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease. Hampel H; Shen Y Scand J Clin Lab Invest; 2009; 69(1):8-12. PubMed ID: 18609117 [TBL] [Abstract][Full Text] [Related]
15. Paradigm shift redefining molecular, metabolic and structural events in Alzheimer's disease involves a proposed contribution by transition metals. Defined lengthy preclinical stage provides new hope to circumvent advancement of disease- and age-related neurodegeneration. Cavaleri F Med Hypotheses; 2015 May; 84(5):460-9. PubMed ID: 25691377 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic impact of rHuEPO on abnormal platelet APP, BACE 1, presenilin 1, ADAM 10 and Aβ expressions in chronic kidney disease patients with cognitive dysfunction like Alzheimer's disease: A pilot study. G V; S K; Sureshkumar ; G S; S S; Preethikrishnan ; S D; A S; D B; Riya ; P V Biomed Pharmacother; 2018 Aug; 104():211-222. PubMed ID: 29775888 [TBL] [Abstract][Full Text] [Related]
18. Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. Furukawa K; Sopher BL; Rydel RE; Begley JG; Pham DG; Martin GM; Fox M; Mattson MP J Neurochem; 1996 Nov; 67(5):1882-96. PubMed ID: 8863493 [TBL] [Abstract][Full Text] [Related]
19. Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment. Zhong Z; Ewers M; Teipel S; Bürger K; Wallin A; Blennow K; He P; McAllister C; Hampel H; Shen Y Arch Gen Psychiatry; 2007 Jun; 64(6):718-26. PubMed ID: 17548753 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease. Liu CG; Wang JL; Li L; Wang PC Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]